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1. INTRODUCTION AND REVIEW  
OF LITERATURE 
The heredity of behavioural traits in humans was obvious already to Plato (427–
347 B.C.) who in Book V of the Republic (Plato, trans. 1901) described an ideal 
state that is ruled by the elite class. He suggested that matching the best with the 
best, and rearing their offspring with attention would lead to the expected, 
beneficial results as projected from the parental characteristics. However, in 
addition to his notice of the need of rearing with attention, he also understood 
that ideal provenance is not infallibly predictive and suggested universal 
education to all citizens, so that the inferior offspring of elite class could be 
demoted, and the offspring of the lower class who show merit could be 
promoted. Considering the extreme standpoints in the history of nature-nurture 
controversy, Plato represented a rather balanced view of the roles of both nature 
and nurture. However, the specific nature of both heredity and environment, and 
interplay between them, is still only partly understood. Desire for knowledge 
and need for new treatments drives research towards understanding how the 




1.1. Psychiatric disorders,  
genetic vulnerability and environment 
1.1.1. Environment and stress 
The theory of stress and general adaptive syndrome was first proposed by Hans 
Selye (1936) as a theory of universal bodily responses of the organism under 
adverse conditions. So stress is a global response of the body to any demand or 
stressor, external or internal. This groundbreaking theory has since then been 
transformed to many more specific versions, including those focusing on indivi-
dual coping styles where stress responses are considered triggered by experiences 
only if the individual perceives them adverse (Goldstein & Kopin 2007).  
Stress responses may follow a time-dependent pattern in which short-term 
stressors elicit adaptive changes by the organism whereas long-term or chronic 
stressors evoke maladaptive changes, observable as detrimental changes in 
various physiological systems, including the CNS (Chrousos 2009; Luine 2007; 
Nugent et al. 2011). Stress reactions are orchestrated by the activity in the 
hypothalamus-pituitary-adrenal (HPA) axis, a neuroendocrine system involved 
in neural, hormonal, and behavioural responses to stressors. Abnormalities in 
HPA function as a result of stress overload involve changes in monoaminergic, 
glucocorticoid, and neuropeptide systems, largely triggered by corticotropin-
releasing factor (CRF) release (Chrousos 2009; Gillespie et al. 2009). Long-
term persistent alterations in these systems may lead to psychiatric disorders, 
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including mood and anxiety disorders and substance use disorders, sometimes 
referred to as disorders of the stress system (Chrousos 2009).  
Stress responses have repeatedly been documented as different in males and 
females (reviewed by Luine 2007). Effects of the same chronic stressor on 
cognition and anxiety have been shown to differ by sex (Bowman et al. 2009; 
Kumsta et al. 2007). This may be because hormonal and other physiological 
systems differ in males and females, but may also suggest that males and 
females perceive the same stressor differently. Indeed, stress- and sex-
dependent neurochemical changes have been documented in both humans and 
animals (Bangasser et al. 2010; Marin et al. 2011). The most natural way of 
explaining sex differences is derived from distinct endocrine environments in 
males and females: counteractions take place between the HPA axis and the 
hypothalamo–pituitary–gonadal (HPG) axis, from which sex hormones are the 
end products. While cortisol has inhibitory effects at the HPG-axis, hypothalamic 
regulation of the HPA axis is suppressed by testosterone (Terburg, Morgan & van 
Honk 2009) explaining why the sexes differ in stress-induced HPA activity 
(Kudielka & Kirschbaum 2005; Marin et al. 2011). These differences are also 
thought to explain sex differences in the prevalence of affective, anxiety and 
substance use disorders (Bangasser et al. 2010; Luine 2007; Witt 2007).  
While considering life stress and environment in relation to psychiatric 
disorders, controversies remain concerning which aspects of life stress are 
important and how to measure stressors (reviewed by Monroe 2008). Research 
has documented a wide range of adverse experiences and chronic stresses like 
war, natural disaster, adverse family environment or severe maltreatment. Stress 
reactions begin already in prenatal environment and continue throughout life 
into late years. Much of it apparently remains well compensated for. There 
seems to be an agreement of opinion that the most detrimental stress originates 
from early developmental stages up to adolescence (Chrousos 2009; Luine 
2007; Nugent et al. 2011). So exposures to trauma, maltreatment and neglect in 
childhood have been identified as major risk factors for psychopathology in 
adulthood, especially for mood and anxiety disorders (Gillespie et al. 2009). 
However, individuals have a wide variety of responses to stress and not all the 
subjects with history of stressful life events develop a psychiatric disorder. 
While some individuals are sensitive to adverse experiences and develop a 
psychopathology, others seem to be resilient by staying symptom free even after 
experiencing significant adversities. Rutter (2006) has defined resilience as 
“implying a relative resistance to environmental risk experiences, or the 
overcoming of stress or adversity”. Sources of resilience come from psycho-
logical and social resources as well as from genetic factors. According to twin 
studies, resilience is highly heritable (Boardman, Blalock & Button 2008; 
Rutter 2006). So it is suggested that high levels of early life trauma lead to 
disease through the developmental interaction of genetic variants with neural 
circuits that regulate emotion, together mediating risk and resilience in adults 
(Gillespie et al. 2009). 
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1.1.2. Personality and psychiatric risk 
Personality and psychopathology have been relatively distinct research objects, 
one being rather dealt with in psychology and the other as the domain of 
psychiatry. Researchers have largely agreed about the existence of basic 
temperaments, and while normal ranges of temperament manifest as perso-
nality, extremes of the temperament confer the risk of psychopathology. Propo-
sals for the construction of a structurally valid model of psychopathology that 
draws on the structure of personality for both Axis I and Axis II disorders have 
been made (e.g., Kruger & Eaton 2010). 
Mood and anxiety disorders are the most common psychiatric disorders with 
12 month prevalence in European countries of 14% and 7.8%, respectively 
(Wittchen et al. 2011). Mood and anxiety disorders have significant comor-
bidity with each other and also with alcohol use disorders: among subjects with 
lifetime affective disorder, 41.4% had lifetime anxiety disorder and 40.3% had 
lifetime alcohol use disorder (Hasin et al. 2005). Affective disorders and 
comorbidity with alcohol use and anxiety disorders are associated with high 
suicidality (Wasserman 2001).  
Males and females have different prevalence of affective, anxiety and 
substance use disorders. While mood and anxiety disorders are at least twice as 
common in females compared to males, substance use is at least three times 
more common in males (e.g., Wittchen et al. 2011). 
Psychiatric diagnoses overlap significantly with extremes of dimensional 
traits, such as Big Five personality dimensions, impulsivity, anxiety, depressive-
ness and self-esteem. This indicates shared, common etiology or influence on 
one another. For example, higher neuroticism and lower extraversion predict 
major depression, and the association arises largely because neuroticism shares 
genetic risk with depression (Kendler et al. 2006). On the other hand, anxiety is 
not specific for anxiety disorders only, e.g., high anxiety often accompanies and 
precedes an affective disorder even when no anxiety disorder was diagnosed 
(Moffitt et al. 2007; Wassermann 2001). Anxiety and neuroticism are associated 
also with substance abuse and dependence and all these constructs are 
associated with impulsivity and extraversion (Acton 2003; Chartier, Hessel-
brock & Hesselbrock 2010; Ersche et al. 2010; Iacono, Malone & McGue 
2003). Subjects with affective/anxiety disorders and suicidal behaviour usually 
exhibit low self-esteem (Mann et al. 2003; Wassermann 2001; Wild, Flisher & 
Lombard 2004). Self-esteem, the affective or evaluative appraisal of one’s self, 
is linked with adaptive personality functioning and has substantial genetic 
origin (Neiss, Sedikies & Stevenson 2002). 
The high heritability (Burmeister, McInnis & Zöllner 2008) and comorbidity 
of mood, anxiety and substance use disorders suggest shared genetic and 
environmental factors (Domschke & Reif 2012; Heinz et al. 2001; Kendler et al. 





1.1.3. Psychiatric risk alleles and gene-environment interactions 
Much of the evidence of genetic background of mental health, and more 
specifically on affective and anxiety disorders, is derived from studies on 
monoaminergic systems. This is because of the relative success of the candidate 
gene approach that has placed focus on detection of functional variants of genes 
known to regulate neuronal activity that is affected by known psychoactive 
drugs. The effects of common genetic variants are however difficult to detect as 
these only have small effects on phenotype.  
In addition, alleles mostly exert their influence under specific environmental 
conditions, as shown in the pioneering studies of Caspi and colleagues on 
monoaminergic genes, behaviour and depression (Caspi et al. 2002; Caspi et al. 
2003). Since then, the number of studies considering G × E effects is ever 
increasing. As a complex disorder, depression is caused by both biological and 
environmental factors, and has been suggested to have disturbances in 
monoamine neurotransmission in the CNS (Harro & Oreland 2001; Moret & 
Briley 2011).  
Abnormalities in the HPA axis in response to increased levels of stress are 
often found to be associated with dysregulations in the serotonergic system, and 
to be relevant in mood disorders and in suicidal behaviour (Mandelli & Serretti 
2013; Pompili et al. 2010). Involvement of the serotonergic dysfunction has also 
been described at the level of gene variants. As an example, one of the most 
studied psychiatric risk gene variants is the short allele of the serotonin 
transporter promotor polymorphism, 5-HTTLPR (Lesch et al. 1996; Lesch 
2004) that mediates reactivity to environmental factors: the s-allele carriers 
show bad mood, less effective adaption, and in some cases depression, in 
response to environmental adversities (reviewed by Bagdy et al. 2012).  
Besides mood disorders, G × E effects on the serotonin and HPA axis 
contribute to anxiety disorders (reviewed by Nugent et al. 2011). Despite of 
high heritability (up to 70%, Burmeister et al. 2008), the evidence for G and G 
× E effects on alcohol dependence and abuse is scarce compared to affective 
and anxiety disorders (reviewed by Young-Wolff et al. 2010). However, again, 
monoaminergic genes are the most studied players in alcohol research as well 
(Young-Wolff et al. 2010).  
In addition to deleterious effects that gave them the name, psychiatric risk or 
vulnerability alleles ought to have also positive effects, otherwise they would go 
extinct. Indeed, many gene variants that have been associated with higher 
psychiatric risk have parallel advantages, and these effects are best observable 
in the background of supportive environment. So Belsky et al. (2009) have 
suggested a differential susceptibility model where some individuals are not 
only more sensitive to negative experiences but they react more adaptively also 
to favourable experiences. Accordingly, the 5-HTTLPR s/s-genotype that has 
been associated with higher risk for affective dysregulation and suicide risk in 
the background of stressful life events had the lowest scores of depressiveness 
and suicidality in the absence of adverse life events (Caspi et al. 2003). Similar 
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pattern has emerged in other studies: the s-allele carriers were vulnerable to 
adverse environment, but in the absence of adversities, they had far lower 
depression scores compared to subjects with no risk allele (e.g., Brummett et al. 
2008; Eley et al. 2004).  
The progress in understanding complex disorders and traits has not been as 
fast as expected. In addition to the complexity of their genetic background, the 
reasons for non-replicable or even contradictory results may lie in differently 
specified and measured traits, principles of selecting subjects, not accounting 
for environmental factors or measuring environmental influences differently. 
Still, a lot can be done for revealing G × E effects by investing into study design – 
using population-representative samples, conducting longitudinal designs, 
introducing dimensional phenotypes parallel to the categorical disease pheno-




1.2. Neuropeptide S system 
“Neuropeptides are substances with a peptide structure that are synthetized in 
nervous tissue and used there as messenger molecules. Some neuropeptides 
fulfill all criteria for a neurotransmitter and may have additional roles as 
neuromodulators or growth factors” (Encyclopedia of Psychopharmacology). 
Neuropeptides are involved in the regulation of wide range of physiological 
functions such as arousal, sleep, reward, metabolism, food intake, reproduction, 
stress response, learning and memory. Neuropeptide S (NPS) and its G-protein 
coupled receptor NPSR constitute a relatively novel neuropeptide system that is 




1.2.1. Biochemistry, chemical neuroanatomy,  
physiology and pharmacology 
Neuropeptide S (NPS) is a 20-amino-acid peptide acting as a neuromodulator 
by binding to a G-protein coupled receptor, now referred to as NPSR (Xu et al. 
2004).  
NPS precursor is present in tetrapods, including mammals, birds, reptiles and 
amphibians, and sequence analysis has revealed that it is evolutionarily highly 
conserved (Reinscheid 2007). The N-terminus is identical in all species 
suggesting it to be the bioactive part of the NPS. The neuropeptide S receptor, 
NPSR, is a typical G-protein coupled receptor (Xu et al. 2004) that was first 
identified as the G-protein coupled receptor 154 (GPR154, Sato et al. 2002), or 
the vasopressin-like receptor VRR1 (Gupte et al. 2004) as well as the G-protein 
coupled receptor for asthma susceptibility GPRA (Laitinen et al. 2004). The 
corresponding encoding gene is located on chromosome 7p14.3. NPSR-like 
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sequence has been identified in hemichordates and cephalochordates, 
suggesting an early emergence (Pitti & Manoj 2012). In humans, the closest 
homologs of NPSR are vasopressin-like receptors (Pitti & Manoj 2012).  
Alternative splicing of human NPSR mRNA produces multiple isoforms of 
NPSR but only few full-length variants produce functional receptors that are 
transported into the plasma membrane (Laitinen et al. 2004; Reinscheid et al. 
2005; Vendelin et al. 2005).  
In rat brain, NPS precursor mRNA is highly expressed in the brainstem area 
between locus coeruleus and the Barrington`s nucleus, while scattered mRNA 
signals have also been detected in amygdala and hypothalamus (Xu et al. 2004). 
In contrast, NPSR is expressed in many brain areas including amygdala, 
thalamus, hypothalamus, hippocampus, preoptic area and orbital cortex (Xu et 
al. 2004; Xu et al. 2007). The majority of NPS-expressing neurons in the locus 
coeruleus area and principal sensory trigeminal nucleus are glutamatergic, while 
NPS neurons in lateral parabrachial nucleus co-express corticotropin releasing 
factor (Xu et al. 2007). The alongside localisation of the NPS neurons with the 
noradrenergic neuronal cluster in locus coeruleus suggests that this brainstem 
area may contain two independent transmitter systems that modulate arousal 
and vigilance (Xu et al. 2004; see below).  
The NPS precursor and receptors are also found outside of CNS: NPS in 
epithelia of several organs (Vendelin et al. 2005; Xu et al. 2004), and NPSR 
mRNA in human macrophages and eosinophils (Pulkkinen et al. 2006) where 
their expression is increased during inflammatory diseases (d´Amato et al. 
2010; Camilleri et al. 2010; Laitinen et al. 2004; Vendelin et al. 2005).  
NPS activates NPSR at subnanomolar concentrations, consecutively inducing 
mobilization of intracellular calcium, increasing intracellular cAMP formation, 
and stimulating phosphorylation of mitogen-activated protein kinase (Rein-
scheid et al. 2005; Xu et al. 2004). 
The NPS system modulates the release and action of other essential neuro-
transmitters and hormones: NPS enhances glutamatergic neurotransmission in 
amygdala (Jüngling et al. 2008), stimulates dopaminergic activity in the medial 
prefrontal cortex and the nucleus accumbens (Mochizuki et al. 2010; Si et al. 
2010), and inhibits the release of serotonin and noradrenaline in the frontal 
cortex (Raiteri et al. 2009). NPS also increases plasma ACTH and corti-
costerone levels indicating the role of NPS in stimulation of the HPA axis and 
in stress response (Smith et al. 2006). A role for NPS in the modulation of stress 
response in rodents was also found by Ebner et al. (2011) where stress led to 
increased NPS levels in amygdala, and by Chauveau et al. (2012) where NPS 
injection to amygdala prevented stress-induced changes of aversive behaviours. 
So, the localisation of NPS and NPSR mRNA, their co-expression with 
other neurotransmitters, and impact on the release or action of other bioactive 
substances all suggest that neurotransmission using NPS modulates various 
physiological functions like arousal, anxiety, energy homeostasis, stress 
response, pain, learning and memory. Indeed, the evidence of the functional 
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involvement of the NPS system in these important functions is accumulating as 
further described below. However, data from humans remain scarce.  
 
 
1.2.2. Neuropeptide S receptor gene (NPSR1) A/T  
polymorphism (Asn107Ile) in humans 
The most extensively studied receptor isoforms expressed in brain are the 
NPSR1 Asn107 and NPSR1 107Ile. The NPSR1 gene has an A/T functional 
single-nucleotide polymorphism (rs324981) that is responsible for an Asn-Ile 
exchange in the first extracellular loop of the receptor protein at position 107. 
NPS has up to 10 times higher potency on the 107Ile (T-allele) encoded receptor 
compared to Asn107 (A-allele) in terms of more effective signal transduction and 
mobilization of intracellular calcium, stimulation of cAMP synthesis and 
induction of MAPK phosphorylation (Reinscheid et al. 2005). Another NPSR 
variant, expressed in epithelia of several organs, contains alternatively spliced 
C-terminus and shows a similar pharmacological profile to NPSR1 Asn¹⁰⁷ 
(Reinscheid et al. 2005). 
The rs324981 A/T functional polymorphism was soon after initial discovery 
found to be linked to emotional processing, and anxious, fear- and activity-
related traits (Dannlowski et al. 2011; Domschke et al. 2011; Donner et al. 
2010; Okamura et al. 2007; Raczka et al. 2010). The precise nature of this 




1.2.3. NPS modulates anxiety and arousal 
NPS has a rather unusual profile in animal studies: It elicits arousal paralleled 
by an anxiolytic-like effect (Leonard et al. 2008; Pulga et al. 2012; Reinscheid 
2008; Rizzi et al. 2008; Smith et al. 2006; Xu et al. 2004). This has led NPS 
being called “an activating anxiolytic” (Guerrini et al. 2010; Koob et al. 2004). 
Specifically, NPS stimulates locomotor activity, increases wakefulness and 
reduces burying behaviour and other anxiety-related behaviours in both mice 
and rats (Leonard et al. 2008; Lukas & Neumann 2012; Paneda et al. 2009; 
Pape et al. 2010; Pulga et al. 2012; Rizzi et al. 2008; Smith et al. 2006; 
Wegener et al. 2012; Xu et al. 2004; Zhao et al. 2012). In addition, NPS 
facilitates the extinction of fear-related memory (Lukas & Neumann 2012). The 
locomotor activity enhancing effect is most likely caused by NPS action on the 
HPA axis because NPS increased the release of CRF, and the CRF antagonist 
blocked the locomotor enhancing effect of NPS without affecting its anxiolytic 
action (Paneda et al. 2009; Smith et al. 2006).  
Rodent studies have led to the expectation that the more active NPS-system 
should be associated with higher arousal also in humans. Indeed, the T-allele of 
the NPSR1 gene A/T polymorphism (Asn107Ile) that encodes for the more active 
5
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receptor isoform has been associated with arousal expressed by higher heart rate 
(Domschke et al. 2011); stronger reactions to aversive stimuli (Dannlowski et 
al. 2011; Klauke et al. 2014; Raczka et al. 2010; Tupak et al. 2013); later 
bedtime in a genome wide study of sleep and circadian rhythm phenotypes 
(Gottlieb, O’Connor & Wilk 2007); and higher prevalence of panic disorder 
(Domschke et al. 2011; Donner et al. 2010; Okamura et al. 2007).  
Affective and anxiety disorders may develop in consequence of an interplay 
between biological predisposition and environmental factors like adverse life 
events and family environment (e.g., Domschke & Reif 2012; Harro 2010). 
Before studies leading to the present dissertation, there had been only one gene 
x environment (G × E) interaction study with NPSR1 probing the Anxiety 
Sensitivity Index (ASI) (Klauke et al. 2014, published online 2012) which 
however was limited by the retrospective assessment of life events and the use 
of a rather specific psychometric scale. A few animal studies with NPS have 
also directly dealt with stress regulation: forced swim stress induced release of 
NPS in the amygdala (Ebner et al. 2011), and administration of NPS into the 
amygdala facilitated extinction of conditioned fear responses (Chauveau et al. 
2012; Jüngling et al. 2008). Such evidence would indirectly support the 
hypothesis that subjects with more effective NPS-ergic neurotransmission, e.g., 
subjects with the NPSR1 TT genotype, should be able to deal better with stress, 
i.e., be more resilient. Nevertheless, as mentioned above, so far the T-allele has 
rather been associated with psychiatric conditions. 
Stress is differently perceived and expressed in males and females, as 
discussed above, and gender related effects of NPSR1 have been already 
reported (Dannlowski et al. 2011; Domschke et al. 2011; Okamura et al. 2007). 
This is not surprising as the NPS system interacts with the HPA axis (Paneda et 
al. 2009; Smith et al. 2006). In addition, in the G × E study by Klauke et al. 
(2014), the NPSR1 T-allele carriers had higher scores in Anxiety Sensitivity 
Index if reporting higher number of adverse life events. It follows that Sex × 
NPSR1 and Environment × NPSR1 effects are expected. 
 
 
1.2.4. NPS system and reward 
Central administration of NPS enchances dopaminergic neurotransmission 
(Mochizuki et al. 2010; Si et al. 2010) that in turn is known to be related to 
reward-associated behaviour and addiction. In rodents, activity of the NPS 
system has been associated with addictive behaviours in several studies 
(reviewed by Cannella et al. 2013) but the direction of the association is 
equivocal because in some experiments, higher NPS-ergic activity is related to 
substance seeking (Cannella et al. 2009a; Cao et al. 2011; Paneda et al. 2009), 
and in others it appears as protective against substance use and dependence 
(Badia-Elder et al. 2008; Enquist et al. 2012; Ruggeri et al. 2010). In more 
detail, administration of NPS facilitated reward seeking and induced positive 
reinforcement (Cao et al. 2011), and reinstated cocaine (Paneda et al. 2009) and 
19 
alcohol seeking in rodents (Cannella et al. 2009a). On the other hand, NPS 
administration decreased alcohol intake in two alcohol-preferring rat lines 
(Badia-Elder et al. 2008; Cannella et al. 2009b), that are known for their 
anxious phenotype and therefore hypotesised to consume alcohol for its 
anxiolytic effects (Cannella et al. 2013). In line with this, Enquist et al. (2012) 
showed that injection of NPS into the basolateral amygdala promoted anxiolysis 
after chronic ethanol consumption. So it is possible that, in alcohol preferring 
rats, NPS decreases ethanol consumption not because it acts on reward 
mechanisms, but rather because of its anxiolytic-like properties (Cannella et al. 
2013).  
These seemingly controversial findings, however, are not surprising as low 
NPS-ergic activity is associated with anxiety, whereas high NPS-ergic activity 
is linked to arousal, hyperlocomotion and impulsivity (e.g., Rizzi et al. 2008; 
Xu et al. 2004), and substance use is related to both anxiety and impulsivity 
(Acton 2003; Chartier et al. 2010; Ersche et al. 2010; Grant et al. 2004; Iacono 
et al. 2003). However, up to now, there are no studies on NPS or NPSR1 effects 
on substance use in humans. As NPSR1 is involved in emotional processing and 
arousal in both humans and animals, and NPS system modulates reward and 
addiction in animals, the search for evidence of NPSR1 involvement in 





2. AIMS OF THE STUDY 
The general aim of this dissertation was to examine the association of a 
functional NPSR1 rs324981 A>T polymorphism (Asn107Ile) with a variety of 
behavioural and physiological measures that, based on the literature, could have 
been hypothesized to be affected by inter-individual differences in NPS-
mediated neurotransmission. This was facilitated by access to multidisciplinary 
databases from large population-derived samples. Particular emphasis was 
placed on possibility of occurrence of G × E interactions, and on the role gender 
may play in such interactions. 
 
More specifically, the research questions were: 
1. Is the NPSR1 A/T polymorphism associated with personality traits, and 
whether any eventual associations depend on age, sex, stressful life events 
and family environment? 
2. Is the NPSR1 A/T polymorphism associated with impulsivity and ADHD-
related traits, and whether any eventual associations depend on age, sex, 
stressful life events and family environment?  
3. Is the NPSR1 A/T polymorphism associated with depressiveness, anxiety 
and self-esteem, and whether any eventual associations depend on age, sex, 
stressful life events and family environment? 
4. What is the relationship between the NPSR1 A/T polymorphism and 
anxiety and mood disorders, and whether any associations depend on sex 
and environmental factors? 
5. Is the NPSR1 A/T polymorphism is associated with suicide attempts, and 
whether the association is modified by sex and environmental factors?  
6. Are there links between NPSR1 A/T polymorphism and alcohol use and 
alcohol use disorders, and whether any eventual links depend on age, sex, 
stressful life events and family environment?  
7. What are the mediating traits in the possible association of NPSR1 A/T 
polymorphism with alcohol use and alcohol use disorders, accounting for 
sex and environmental factors? 
8. Does the NPSR1 A/T polymorphism affect sleep, and if yes, does this 




3. MATERIALS AND METHODS 
3.1. Subjects 
3.1.1. The Estonian Children Personality Behaviour and Health Study 
(Papers I, II, III and V) 
Data of both birth cohorts of the Estonian sample for the European Youth Heart 
Study (EYHS, 1998/99), which was subsequently incorporated into the longi-
tudinal Estonian Children Personality Behaviour and Health Study (ECPBHS) 
were used for most of the analyses in this dissertation. The rationale and 
procedure of sample formation have been described in detail elsewhere (Harro 
et al. 2001; Tomson et al. 2011), but it is pertinent to point out that this sample 
is population-representative and has low attrition rate. The total number of 
subjects in the first wave in 1998/99 was 1176; 583 in the younger cohort 
(MAge=9.6±0.5) and 593 in the older cohort (MAge=15.6±0.6). The follow-up 
studies for the younger cohort took place in 2004 (n=483, MAge=15.3±0.5) and 
2007 (n=453, MAge=18.3±0.5); for older cohort, the follow-ups were in 2001 
(n=454, including 62 additional subjects, MAge=18.4±0.7) and 2008 (n=540, 
MAge=24.7±0.7). All subjects were of Caucasian origin. EYHS and ECPBHS 
have been approved by the Tartu University Ethics Review Committee on 
Human Research. All participants, and the parents, gave informed consent. 
 
 
3.1.2. The Estonian Psychobiological Study of Traffic Behaviour  
(Paper IV) 
The database of the Estonian Psychobiological Study of Traffic Behaviour 
(EPSTB; Eensoo et al. 2010; Paaver et al. 2006; Paaver et al. 2013) that 
includes two population derived samples was used. One (Car Drivers) was 
formed of car driving male subjects selected randomly from the driving-licence 
database of the Estonian Motor Vehicle Registration Centre as a control group 
to traffic law violators (original N=509; MAge=36.7±11.8; Paaver et al. 2006). 
These participants filled in impulsivity self-reports during a visit to laboratory 
in 2001–2003. The other sample (Driving School; original N=1866, 
MAge=24.0±8.0) was formed during an intervention study in driving schools on 
students applying for a passenger car driving license (Eensoo et al. 2010; Paaver 
et al. 2013). In brief, 24 driving schools out of 54 in the two biggest cities in 
Estonia, Tallinn and Tartu, were considered eligible and agreed to participate. 
Subjects from the total of 113 study groups in these driving schools filled in 
questionnaires in a driving school lesson, and some responded to an additional 
questionnaire sent by e-mail 2–3 years later. We have used data from years 
2007 when impulsivity and mild social deviance were measured and 2010 when 
attention deficit hyperactivity disorder related symptoms were self-reported. 
Altogether 773 subjects (41%) donated blood samples (males, n=318, 
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MAge=22.6±7.4; females n=455, MAge=25.1±8.2 during the original sampling). 
This study was approved by the institutional Ethics Review Committee of 





Personality traits of the five-factor model (Papers I, II and III) were measured 
in ECPBHS by self-reports with the Estonian version of Revised NEO 
Personality Inventory (NEO-PI-R, Kallasmaa et al. 2000), EPIP-NEO (Mõttus 
et al. 2006) which is a semantically simplified full-length version of NEO-PI-R, 
or Estonian Brief Big Five Inventory (EBBFI) which is a shorter and semanti-
cally simplified questionnaire (Laidra et al. 2006; Harro et al. 2009). Personality 
data were collected from the younger cohort at ages 15 (EPIP-NEO) and 18 
(EBBFI), and the older cohort at age 15 (EBBFI), 18 and 25 (both NEO-PI-R). 
As the data have been collected with different instruments all scores were trans-
formed into z-scores for statistical analysis. 
 
 
3.2.2. Impulsivity and symptoms of attention deficit  
hyperactivity disorder 
Impulsivity was self-reported (Papers I, III and IV) by subjects of all samples. 
We used the Adaptive and Maladaptive Impulsivity Scale (Paaver et al. 2006; 
Laas et al. 2010) with subscales measuring Fast decision making and 
Excitement seeking (functional or adaptive impulsivity), and Disinhibition and 
Thoughtlessness (dysfunctional or maladaptive impulsivity). In ECPBHS, the 
younger cohort filled AMIS at ages 15 and 18, and the older cohort at ages 18 
and 25. Subjects of both Car Drivers and Driving School samples filled AMIS 
once. We have also used Barratt Impulsivity Scale 11th version (BIS-11, Patton 
et al. 1995; Estonian version described by Paaver et al. 2007), filled in by the 
ECPBHS younger cohort at ages 15 and 18, and by the older cohort at age 25; 
and by the sample of Driving School during initial evaluation. 
ADHD symptoms were reported by teachers (Kiive et al. 2010) in ECPBHS 
at ages 9, 15 and 18 using the Hyperactivity Scale and SNAP-IV (Papers I and 
III). The Hyperactivity Scale consists of three items (Aggressiveness, Motor 
restlessness, and Concentration difficulties), and Hyperactivity score was calcu-
lated by summing the scores of Motor Restlessness and Concentration Diffi-
culties (af Klinteberg & Oreland 1995). Swanson, Nolan & Pelham Question-
naire SNAP-IV consists of two subscales, Inattention and Hyperactivity/ 
impulsivity (Swanson et al. 2001). Adult ADHD Self-Report Scale (ASRS, 
Kessler et al. 2005) was administered to the older cohort of ECPBHS at age 25 
(Papers I and III) and to the Driving School sample about three years after 
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initial assessment (Paper IV). The scales were also dichotomised by upper 5% 
for the hypothetical presence of ADHD for examining categorical NPSR1 
associations in ECPBHS.  
 
 
3.2.3. Psychiatric diagnosis 
Psychiatric assessment based on DSM-IV was carried out in the older cohort of 
the ECPBHS at age 25 by experienced clinical psychologists using the Mini-
International Neuropsychiatric Interview (MINI 5.0.0; Sheehan et al. 1998; 
Estonian version: Shlik et al. 1999) at age 25 (Papers II and III). Substance 
use disorders comprised mainly of alcohol use disorders, so three males with 
NPSR1 genotype who were abusing or were dependent on illicit drugs were 
excluded from analysis for the sake of the clarity. We used lifetime prevalence 
of disorders in this analysis. As of writing this dissertation, psychiatric assess-




History of suicide attempts was self-reported by the subjects of the younger 
cohort of ECPBHS at ages 15 and 18, and by the older cohort at age 18 (Paper 
II). The data of both cohorts at age 18 was combined for analysis. The question 
asked was: “Have you ever tried to attempt a suicide?” with two possible 




Depressiveness was measured by the self-report version of the Montgomery-
Åsberg Depression Rating Scale (MÅDRS; Montgomery & Åsberg 1979) or 
Beck Depression Inventory (BDI; Beck et al. 1961) (Paper II). Subjects of the 
younger cohort of the ECPBHS filled BDI at age 15 and MÅDRS at age 18; and 




The Spielberger State Trait Anxiety Inventory (STAI, Spielberger 1983) was 
used to measure anxiety in Paper II in the ESPBHS. STAI was administered to 






The Rosenberg Self-Esteem Scale (RSES, Rosenberg 1965; Estonian version 
Pullmann & Allik 2000) was used to measure global self-esteem (Paper II). 
Self-esteem is defined as a favorable or unfavorable attitude toward the 
self (Rosenberg 1965). RSES items were self-reported on a 5-point Likert scale 
ranging from 0 (strongly disagree) to 4 (strongly agree) by subjects of both the 
older (ages 15 and 18) and the younger cohort (at age 25) of the ECPBHS.  
 
 
3.2.8. Alcohol use 
Alcohol use (Paper III) was self-reported during the visit to the laboratory 
(Merenäkk et al. 2011) in all waves of the ECPBHS. The measures in 
questionnaires varied by study waves. Alcohol use indices were the age of first 
drink (the age of having the first ½ standard drink in years); alcohol use 
(frequency of alcohol use); heavy drinking (frequency of having five or more 
drinks on a single occasion); being drunk (frequency of drinking to intoxi-
cation); getting drunk deliberately (in past, answers yes/no). Questions about 
alcohol use effects were administered at age 18 to the older cohort only “When 
I drink alcoholic beverages, I feel relaxed”, “When I drink alcoholic beverages I 
feel happier” (1-very likely, 2-likely, 3-unsure, 4-unlikely, 5-very unlikely). To 
reduce skewness, alcohol use indices that were not binary were dichotomised 
except the age of having the first drink. 
 
 
3.2.9. Family relations 
Family relations were self-reported by the subjects of ECPBHS (Papers I, II, 
III and V) with the Tartu Family Relationships Scale (TFRS; Kiive et al. 2010; 
Paaver et al. 2008). TFRS consists of four subscales named Closeness (15 
items, e.g., “Our family is dedicated to each other”, “The marriage of my 
parents is happy”), Support (7 items, e.g., “My family supports me”, “Someone 
in the family helps (has helped) me to feel myself important and special”), 
Misprize (10 items, e.g., “I can make no decision on my own”, “I am 
depreciated at home”), and emotional and physical Abuse (7 items, e.g., “Were 
you ever hit by someone in your family or have you experienced physical 
violence in your family?”). Items were presented on 4 or 5-point Likert scale. 
Based on similarity, the four subscales can be combined to obtain two higher 
order scales Warmth (Closeness and Support) and Maltreatment (Neglect/ 
Misprize and Abuse). A single measure of positive family relationships (FR) 
was formed by subtracting scores of Maltreatment from scores of Warmth. We 
have used only higher order scales Warmth, Maltreatment and Family relations. 
Subjects were divided into low and high groups by median split. 
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3.2.10. Stressful life events 
History of stressful life events (SLE) was self-reported by the subjects of 
ECPBHS (Papers I, II, III and V). The list of adverse life events varied across 
measurement times and consisted of 10–17 (dependent on the study wave) 
stressful experiences including parental death and divorce/-separation, 
unemployed parent, parental alcoholism, poverty, poor living conditions, poor 
health, accidents and traumas, physical abuse, emotional abuse, severe burden/ 
serious concerns, suicidal attempts, leaving home for several days without 
telling anyone, depression of a close relative, committed suicide, or suicide 
attempt of a close relative (Reif et al. 2011). Subjects were divided into low and 
high SLE exposure groups by median split. 
 
 
3.2.11. Mild social deviance 
Mild social deviance was measured by the Social Motivation Questionnaire 
(SMQ, West et al. 1993) in the Driving School sample (Paper IV). SMQ is a 
short instrument consisting of 10 items on a 3-point Likert scale; and it 
measures mild social deviance in imagined situations, which might harm the 
interests of others. 
 
 
3.2.12. Anthropometric measures 
Anthropometric measurements were available for ECPBHS and carried out in 
both cohorts in all waves (subjects with all data including NPSR1 by study 
waves: older cohort n=575, 369 and 449, respectively; younger cohort n=563, 
469 and 437, respectively). Body mass index (BMI, kg/m2) was calculated 
based on height and weight and used as a covariate in Paper V because BMI 
has been found to be associated with sleep duration and quality in adolescents 
(Shochat et al. 2014). 
 
 
3.2.13. Sleep duration and bedtime 
Sleep-related measures were available for the ECPBHS cohorts (Paper V). For 
the first study wave in 1998/99, sleep duration was calculated from self-reports 
of bedtime and wake-up time (Ortega et al. 2011). Subjects answered two 
questions: (1) “What time do you usually get up on a School day?” with four 
possible answers ranging from <06:30 to >07:30, at 30 min intervals; and (2) 
“What time do you usually go to bed on a School day?” with four possible 
answers ranging from <20:00 to >22:00, at 1 h intervals. In next waves, the 
questions administered to both birth cohorts were: (1) „When do you usually go 
to bed?“ with five possible answers ranging from <21h to >24h, and (2) „How 
long do you usually sleep?“ with five time intervals from <7h to >12h. Sleep 
7 
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duration was transformed into a two-category variable <9h and >9h for ages 9–
18 according to the National Sleep Foundation that defines optimal sleep in 
children and adolescents as sleeping more than 9 h (National Sleep Foundation 
2006). At age 25, five time intervals from <6h to >11h were used, and sleep 
duration was transformed into a two-category variable <8h and >8h for further 
analysis. Both bedtime and sleep duration were self-reported. 
 
 
3.2.14. Sleep-related difficulties 
In all the waves, reports of sleep-related difficulties were obtained (Paper V): 
(1) difficulties with falling asleep in the evening; (2) difficulties with getting up 
in the morning; and (3) tiredness in the morning. Six-point Likert scale was 
used, from 1 – no difficulties to 6 – difficulties almost every day. We have used 
parental reports for the younger cohort in all three waves (subjects with 
genotype data: n=533 at age 9, n=444 at age 15, and n=404 at age 18), and for 
the older cohort at ages 15 (n=482) and 18 (n=332). At age 25, only self-reports 
were available (n=471). Composite score of sleep-related problems was formed 
by summing the scores of all three questions. 
 
 
3.2.15. NPSR1 rs324981 A/T polymorphism (Asn107Ile) genotyping 
The alleles at the NPSR1 rs324981 (Asn107Ile) SNP locus were amplified from 
DNA isolated from venous blood samples as previously described (Domschke 
et al. 2011). The genotyping was carried out in the Department of Psychiatry of 
the University of Wuerzburg, Germany. Briefly, DNA isolated from venous 
blood samples was amplified by PCR using the primers F: 5`-
GAAGGAAAAAAATTAAAAATGAACCTCCCCAGGATTTCAT and R: 5`-
TCTACCCAGGAGAAAGCGGGCAGTTTGATGCA. Standard PCR was 
carried out in a 20-μl volume containing 45–60 ng of genomic DNA, 10 pmol 
of each primer, 200 μM dNTPs, 0.4 U TaqTM DNA Polymerase (Eppendorf AG, 
Hamburg, Germany), 50 mM KCl, 1.5 mM MgCl2, and 10 mM Tris-HCl (pH 
8.4). After a 5 min denaturation, 35 cycles were carried out each consisting of 
30 s at 94 °C, 30 s at 66 °C, and 60 s at 72 °C, followed by a final extension 
time of 10 min at 72 °C. Amplicons were digested with TasI (Fermentas) (1 U), 
separated for 2 h on a 15 % polyacrylamide gel and visualized by silver 
staining. NPSR1 A/T polymorphism was genotyped in all four samples: in the 
older (n=575) and in the younger cohort (n=563) of the ECPBHS; and in Car 
Drivers (n=491) and Driving School (n=773) of the EPSTB. Genotype 
frequencies were in Hardy-Weinberg equilibrium in all the samples and for both 
sexes (Table 1). 
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3.3. Data analysis 
The NPSR1 genotype distribution by categorical variables was compared with 
Chi-square or Fisher`s exact test; odds ratios (OR) with confidence intervals 
(CI) were calculated as a measure of effect size (Papers I–V). Correlation 
analysis was used to reveal associations between study variables (Papers I–V). 
Analysis of variance and covariance (AN(C)OVA) was used to test the effect of 
NPSR1 and other categorical variables on study variables (Papers I–V). 
AN(C)OVA results are reported as F-statistic, raw p-value, η² as a measure of 
effect size and CI for group means. In figures, whiskers indicate 95% confi-
dence intervals. In Paper III, binary logistic stepwise regression with backward 
elimination of the covariates was used to test if covariates (personality, 
hyperactivity and environmental factors) explain the relationship between the 
genotype and outcome variables. A significance level of ≤0.20 was used to 
allow a covariate into the model, and a significance level of ≤0.25 for a 
covariate to stay in the model (we used enter method for the first data block 
containing genotype effects). The models were built by the age when covariates 
were reported; e.g., for the older cohort, if alcohol related report was attained at 
age 15 we used covariates from age 15; and for predicting AUD and alcohol use 
at age 25, covariates from ages 15, 18 and 25 were used in three separate 
models per outcome variable. The results from regression models for AUD 
were reported as regression coefficient β with 95% confidence interval (CI). 
The results for alcohol use were reported as the direction of the influence of 
significant covariates and the p-value for the genotype effect after accounting 
for covariates. Logistic regression with enter method was used also to predict 
suicide attempts and affective/anxiety disorders (additional analysis for 
dissertation), and sleep duration (Paper V). Calculations were made with 
SPSS.16.0. (SPSS Inc., Chicago, IL, USA) with data in Papers II, III and IV. 
Mixed-effects analysis of variance, e.g., multilevel models (MLM) was used 
for analysing longitudinal effects of the NPSR1 genotype, age, sex, SLE and 
family relations on personality and ADHD scores (Paper I); and on bedtime 
and sleep quality, considering covariates BMI and month filling the question-
naire for Paper V. MLM longitudinal analyses were performed with SAS 9.1.3. 
(SAS Institute Inc., Cary, NC, USA) using PROC MIXED. Contrasts were 
calculated for significant MLM effects. Results from MLM were reported in the 




4. RESULTS AND DISCUSSION 
4.1. The NPSR1 A/T genotype distribution  
in published studies 
The distribution of the NPSR1 A/T genotype in studies published so far reveals 
significant differences. Some of these reflect differences between ethnic groups 
(Table 1). The TT genotype was most common in a Japanese sample and least 
common in German samples. In Estonia, the genotype frequencies yield a rather 
balanced distribution of both alleles. Psychiatric “risk genotypes”, such as the S 
allele of the 5-HTTLPR and the Met allele of BDNF Val66Met, are known to be 
less frequent in Caucasians but more common in Asian people (e.g., Goldman et 
al. 2010; Pivac et al. 2009), Estonian samples being observed as typical 
Caucasian groups. In case of NPSR1, Estonians appear to position between 
Japanese and the German Caucasian samples. However, we cannot make a strict 
conclusion about the allelic variation of the NPSR1 rs324981 in this regard as 
we know of the distribution in only one Asian sample, and there is non-
negligible variation between German samples.  
 
Table 1 The NPSR1 rs324981 genotype distribution in primarily non-clinical samples; 
Chi-square test for differences in ethnic groups. 
The sample 
NPSR1 genotype   
AA AT TT 
Total 
N 
Difference from ... 
sample 
Estonian 




Driving School 191 (24.7%) 400 (51.7%) 182 (23.5%) 773  
Males 84 (26.4%) 164 (51.6%) 70 (22.0%) 318  
Females 107 (23.5%) 236 (51.9%) 112 (24.6%) 455  
Car Drivers 
Males only 
123 (25.1%) 247 (50.3%) 121 (24.6%) 491  
ECPBHS 294 (25.8%) 569 (50.0%) 275 (24.2%) 1138  
Males 136 (26.3%) 258 (49.8%) 124 (23.9%) 518  
Females  158 (25.5%) 311 (50.2%) 151 (24.4%) 620  
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Table 1. Continuation 
The sample 
NPSR1 genotype   
AA AT TT 
Total 
N 




et al. (2007) 
controls 










et al. (2011) 
controls 
264 (34.0%) 366 (47.2%) 146 (18.8%) 776 
 
Klauke et al. 
(2014) 
controls 
131 (27.6%) 245 (51.6%) 99 (20.8%) 475
 
Kumsta et al. 
(2013) 
56 (28.6%) 98 (50.0%) 42 (21.4%) 196 
 
Lennertz et al. 
(2012) 
controls 




4.2. NPSR1 effects on personality, impulsivity and  
ADHD-related symptoms (Papers I and IV) 
We first examined whether the functional NPSR1 rs324981 polymorphism 
influences personality, impulsivity and hyperactive/inattentive behaviours, and 
whether any eventual associations depend on age, sex, stressful life events and 
family relations (Paper I). 
In animal studies, higher NPS-ergic activity that corresponds to NPSR1 
rs324981 T-allele in humans produces arousal concurrently with anxiolytic 
effects (e.g., Pape et al. 2010; Xu et al. 2004) that is a rather unusual profile of 
action as pharmacological compounds that reduce anxiety also reduce arousal 
and activity. Human studies have so far been in agreement on that T-allele is 
associated with arousal (e.g., Dannlowski et al. 2011; Domschke et al. 2011) but 
have also suggested, contrary to animal findings, that T-allele is associated with 
higher anxiety as well (Dannlowski et al. 2011; Domschke et al. 2011; Donner 
et al. 2010; Klauke et al. 2014; Okamura et al. 2007; Raczka et al. 2010).  
The key findings in the ECPBHS sample were: 1) subjects with the NPSR1 
TT genotype had the highest level of impulsive tendencies; 2) subjects with the 
TT genotype were most sensitive to SLE; and 3) subjects with the AA genotype 
were, instead, more sensitive to the family environment. The simplified 
8
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overview of these results is presented in Figure 1. The data have been derived 
from three measurement waves of two separate birth cohorts of ECPBHS. The 
effects on ADHD-related symptoms were apparent in both cohorts, although 
more evident in the younger cohort, whereas the main effects of NPSR1 and 
interaction effect with sex on personality and impulsivity were observed 
primarily in the older cohort due to differences at age 18, and even more 
prominently, in young adulthood at age 25. This is plausible, as a part of ADHD 
symptoms are known to decrease with adolescence and adulthood, while stable 
personality is formed in early adulthood. NPSR1 interaction effects with SLEs 
and family relations on personality, including impulsivity, were observed in 




Figure 1 Simplified overview of the results of the NPSR1 effects and interactions with 
SLE and family relations in the ECPBHS (Paper I). Imp – impulsivity. 
 
 
The results described in Paper IV provide further evidence for the association 
of NPSR1 A/T polymorphism with impulsivity and hyperactivity. These 
analyses used entirely independent samples. Again, subjects, especially males, 
carrying the T-allele had higher scores of both impulsivity and ADHD-related 
symptoms. However, we had no information about exposure to environmental 
adversities for these samples and could not check for G × E effects. 
 
Lifetime adversities 
Adaptive imp ↑ 
Openness to 
Experience ↑ 
ADHD traits ↑ 
Adaptive imp ↓ 
Openness to 
Experience ↓   
ADHD traits ↑   
Maladaptive imp ↑ 








Adaptive imp ↓  





Stable traits and resilience 
to stress AT 
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Impulsive action 
The NPSR1 A/T polymorphism influenced impulsivity as measured by the 
AMIS scale that enables to differentiate between adaptive and maladaptive 
types of impulsivity (Dickman 1990; Paaver et al. 2006) (Papers I and IV). We 
have also measured impulsivity with Barratt Impulsivity Scale but no 
differences between NPSR1 genotypes were observed in any of the samples. 
This obviously suggests that the impulsivity constructs of Barratt significantly 
differ from others with regard to neurobiology that is NPS-related, and informs 




Figure 2 NPSR1 × environment effects on maladaptive impulsivity in the ECPBHS. 
(a) NPSR1 × SLE × Age effects on Disinhibition, t(1, 279)=2.70, p=0.007. (b) NPSR1 × 
Maltreatment effect on Thoughtlessness, t(1, 366)=–2.96, p=0.003, at age 18  
F(2, 311)=0.13, p=0.877, η²=0.001; at age 18 F(2, 247)=3.49, p=0.032, η²=0.018.  
** p<0.01, *** p<0.001, difference from different environment, same genotype and age;  
# p<0.05, difference from different allele, same age and environment; & p<0.05, 
difference from age 18, same genotype and environment; q p=0.06, difference from  
A-allele carriers, same environment and age; ¤ p<0.05, difference from TT genotype, 











































































In the EPSTB sample, male T-allele carriers had higher impulsivity scores; 
however, in Car Drivers, it was higher adaptive impulsivity, whilst in the 
Driving School sample, it was higher maladaptive impulsivity (Paper IV). It is 
important to recognize, that both types of impulsivities are sensitive to G × E 
effects (Paper I). TT homozygotes had significantly higher impulsivity in case 
of high SLE that hypothetically may indicate the rise of activity in response to 
stress (e.g., Figure 2a). This fits well with the modest effects of NPSR1 on 
ADHD related behaviour as rated by teachers, where the TT males had more 
symptoms (Figure 3), and SLE further increased the scores. 
In ECPBHS sample, subjects with the AA genotype, especially males, had 
the steepest elevation in Adaptive impulsivity fom age 18 to 25. AA homo-
zygotes also gained the most from favourable family relations by reacting with 
elevated Adaptive impulsivity and Extraversion, and with lowered Thought-
lessness and Neuroticism (Figures 2b and 4). This may be because supportive 
environment lowers anxiety. On the other hand, unfavourable family environ-
ment increased Thoughtlessness and Neuroticism and lowered Extraversion in 
subjects with AA genotype that may indicate the harmful effects of anxiety 
(Figures 2b and 4). So the NPSR1 effects on both types of impulsivities and 
personality may reflect changes in balance between activity/ arousal and 
anxiety. Such a notion appears to be consistent with animal studies where NPS-
ergic neurotransmission concurrently promotes arousal and lowers anxiety (Lukas 
& Neumann 2012; Rizzi et al. 2008; Wegener et al. 2012; Xu et al. 2004).  
We found no evidence for genotype differences in social deviance that was 
available for the Driving School sample only (for males, n=315, F<0.01, 
p=0.979, η²<0.001; for females, n=449, F=0.77, p=0.381, η²=0.002). While high 
impulsivity may lead to socially irresponsible behaviours, this appears not to be 
the case with NPSR1-related impulsivity. Nevertheless, we cannot rule out G × 
E effects on social deviance. 
In both cohorts, males with the TT genotype of the NPSR1 had more ADHD 
symptoms as observed by teachers (Paper I). Stressful life events further 
increased the ADHD scores in TT genotype. We also found that the TT 
genotype was overrepresented in the upper 5% of ADHD scores at age 15. The 
reason for failing to detect this at older age may be based on the higher dropout 
rate of the subjects with the extreme values of ADHD scores: while overall 94% 
of 15-years-old subjects from younger cohort participated in the next wave, it 
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 Figure 4 NPSR1 × family environment × Age effects on personality in the ECPBHS. 
(a) NPSR1 × Warmth × Age effect on Neuroticism, t(1, 324)=2.53, p=0.012. (b) NPSR1 
× Family relations × Age effect on Extraversion, t(1, 316)=2.02, p=0.044. * p<0.05, ** 
p<0.01, *** p<0.001, difference from different environment, same genotype and age; # 
p<0.05, ## p<0.01, difference from T-allele, same environment and age. 
 
 
As T-allele carriers, especially male TT homozygotes, expressed increased 
activity (Papers I and IV), and higher arousal in the gain-of function T-allele 
carriers has been established previously (e.g., Domschke et al. 2011), NPSR1 
appears as a strong ADHD candidate gene, supported by animal models 
(Reinscheid 2008). This is also consistent with the results of the impulsivity-
related role of the NPSR1 (Papers I and IV). Both ADHD patients and 
individuals with above-average impulsivity are highly responsive to situations 
and easily aroused emotionally, which is in accordance with the enhanced 
reactivity to emotional stimuli in the T-allele carriers (Raczka et al. 2010; 
Dannlowski et al. 2011). Nevertheless, Okamura et al. (2007) reported no 
association of NPSR1 A/T polymorphism with ADHD. Neither have searches 
for ADHD candidate genes pointed towards NPSR1 or its location on chromo-
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2008). So the NPS receptor may rather contribute to ADHD-like behaviour 
dimensionally and through impulsivity and arousal, effects that become evident in 
non-clinical samples and may have public health relevance in general population. 
In response to centrally administered NPS in rodent models, the increased 
locomotor activity is accompanied by wakefulness and reduced sleep (Rizzi et 
al. 2008; Xu et al. 2004; Zhao et al. 2012). In children, hyperactive and 
inattentive symptoms are also related to short sleep duration, so insufficient 
sleep and fighting drowsiness may be causally related to these symptoms 
(Paavonen et al. 2009). NPS-ergic neurotransmission has a direct effect on the 
HPA axis and contributes to the modulation of arousal and anxiety by 
regulating the release of CRF (Paneda et al. 2009; Smith et al. 2006; Zhao et al. 
2012). Speculatively, the human NPSR1 A/T polymorphism may reflect a 
population-level balancing mechanism for fighting drowsiness and low cortical 
activity, and boosting arousal, which is observable to the largest extent in males 
with the TT genotype (Paper I), already mimicking the ADHD symptoms. In 
the EPSTB samples, high impulsivity and hyperactivity were present not 
exclusively in TT homozygotes, but T-allele carriers (Paper IV). We thus may 
suggest that in general population, subjects with the T-allele have higher-
functioning arousal/anxiety system that does not lead automatically to anxiety-
related psychopathology.  
 
Stressful life events and family relations 
There were no differences in evaluating family environment or the occurrence 
of stressful life events by NPSR1 in ECPBHS subjects. However, our findings 
suggest that both AA and TT NPSR1 homozygotes respond to stress more than 
heterozygotes, but the vulnerabilities differ: AA responded more to family 
environment, and TT mainly to stressful life events (Paper I). The fact that the 
AA genotype (the genotype leading to the least active NPSR receptor-mediated 
signal transduction) was reactive to stress may demonstrate that elevation of 
anxiety in adverse family environment is not well compensated for by NPS if 
the receptors are less sensitive. This would be consistent with animal studies 
where NPSR1 knockout mice expressed increased anxiety-like behaviour 
(Duangdao et al. 2009) and administration of NPS acted like an anxiolytic 
(Jüngling et al. 2008; Lukas & Neumann 2012; Wegener et al. 2012; Xu et al. 
2004). Otherwise, subjects with TT and not AA genotype were sensitive to 
adverse life events – they had significantly higher scores of impulsivity, inatten-
tion and motor restlessness (the latter in males only).  
The sensitivity to environment of the T-allele carriers is in accordance with 
previous human studies where all the presumed adverse arousal and anxiety-
related psychiatric effects were limited to T-allele carriers. Similarly, in the 
single previous G × E study (Klauke et al. 2014), NPSR1 TT genotype subjects 
were more sensitive to adverse life events, reporting higher anxiety sensitivity. 
NPS activates HPA axis (Paneda et al. 2009; Smith et al. 2006; Zhao et al. 
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2012), and enhanced acute stress response was recently detected in T-allele 
carriers (Kumsta et al. 2013). Importantly, however, all this is not easily 
compatible with animal studies: a simple deduction from the facts that NPS 
administration evokes anxiolytic effects in rodents, attenuates the expression of 
contextual fear (Meis et al. 2008) and facilitates fear extinction (Jüngling et al. 
2008) would be that in humans the T-allele carriers, especially the TT 
homozygotes, have better functioning in response to stress compared to those 
with A-alleles. Translating our findings that both AA and TT homozygotes are 
less resilient to environmental adversities back to animal studies, one could 
expect divergent effects of NPS on anxiety-related behaviour in radically 
different experimental designs. For another neuropeptide, cholecystokinin, this 
has been reported (see Harro 2006 for review). 
Indeed, what is different in the two measures of environmental adversities 
requires further analysis. Conceivably, less warm family environment overall 
and specific adverse life events are different stressors although they correlate 
moderately. In our sample, these two types of adversities had quite similar 
effects on personality, impulsivity and ADHD-related symptoms. A working 
hypothesis is that the key is the relative subjectivity of the evaluation: while life 
events were mostly reported as having occurred or not (e.g., death of a close 
relative), the family environment assessment was quantitative and based on 
perceptive evaluation. Whether objective or subjective indicators of environ-
mental stress evaluations are used does affect the outcome (Monroe 2008).  
Self-reports of adverse life events may underestimate their occurrence. In 
this study such a bias could affect the results only if underreporting were geno-
type-dependent. This nevertheless cannot be excluded and merits attention in 
future studies.  
It has been reported that NPSR1 A/T polymorphism influences emotional 
evaluation, and T-allele carriers react more strongly to fear-related emotional 
stimuli possibly caused by higher arousal of T-allele (Dannlowski et al. 2011; 
Domschke et al. 2011; Raczka et al. 2010). These findings guide the thinking to 
explanation that the higher response to SLE of subjects with two T alleles could 
be related to arousal mechanisms that are separate from the neurobiology of 
anxiety, and the reaction of AA genotype on family environment in Paper I 
must be anxiety-related as derived from animal studies. Without knowing the 
exact neural mechanisms yet, we can however conclude that a double 
dissociation of perception of family environment (as measured by the scale we 
used) and adverse life events occurs in NPSR1 AA and TT homozygotes, 
resulting in distinct G x E outcomes in personality, impulsivity and ADHD 
symptoms.  
The effects of the NPSR1 AA genotype on personality and impulsivity were 
advantageous in case of favourable family environment, and more so for men 
(Paper I). Nevertheless, the sensitivity to family environment of the subjects 
with AA genotype led to detrimental changes as reflected e.g., in scores of 
Neuroticism in case of adverse family relations.   
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4.3. NPSR1 × environment effects:  
contribution to affective and anxiety disorders,  
and suicidal behaviour (Paper II) 
Considering the evidence of the role of NPS-ergic neurotransmission in the 
regulation of emotional processing (Dannlowski et al. 2011; Domschke et al. 
2011; Klauke et al. 2014; Raczka et al. 2010; Tupak et al. 2013), panic disorder 
(Domschke et al. 2011; Donner et al. 2010; Okamura et al. 2007), and NPSR1 
interactions with the environment in shaping traits (Paper I) that predict anxiety 
and affective disorders (e.g., Lönnqvist et al. 2009), we aimed to clarify the role 
of NPSR1 A/T polymorphism for anxiety and mood disorders in the general 
population, also taking into account the sensitivity of the genotype to 
environmental factors. 
We found that in females with the functionally least active NPSR1 AA 
genotype who had experienced adverse family environment, lifetime affective/ 
anxiety disorders were more prevalent by age 25 (Figure 5a). This higher 
prevalence of psychiatric disorders was accompanied by high anxiety and low 
self-esteem (Figures 6 and 7), traits that both predict affective disorders and 
suicidal behaviour (Domschke & Reif 2012; Mann et al. 2004; Moffitt et al. 
2007; Wasserman 2001; Wild et al. 2004). Indeed, G × E interaction effects had 
been present already in adolescence as reflected in higher depressiveness and 
anxiety, lower self-esteem and higher frequency of suicide attempts in AA 






Figure 5 NPSR1 × Warmth in the family association with affective/anxiety disorders 
and suicide attempts in females of the ECPBHS. (a) Affective/anxiety disorders in the 
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It is also known that the risk for suicidal behaviour is heightened by impulsivity 
(Fawcett 2001; Nock et al. 2008), and the risk for anxiety/affective disorders is 
increased by neuroticism and lowered by extraversion (Bienvenu et al. 2004; 
Kotov et al. 2010). In accordance with this, subjects with the AA genotype who 
experienced adverse family environment developed high maladaptive impul-
sivity and neuroticism, and low extraversion (Paper I) that could contribute to 
suicide attempts and disorders. Hence the question emerges, whether the 
association of the NPSR1 with suicidal behaviour is mediated by these perso-
nality traits or the disorders. Additional analysis to predict suicide attempts with 
the genotype and predictors from earlier age revealed, that besides NPSR1 AA 
genotype, female sex and higher SLE, suicide attempts were only predicted by 
lower extraversion reported three years earlier, and not neuroticism (Table 2). 
The NPSR1 genotype was a stronger predictor of suicide attempts than extra-
version. Similar results were obtained when predicting affective/anxiety dis-
orders (not shown in detail): significant predictors from age 15 were female 
gender (OR=3.15 [1.26–7.90], p=0.014), the AA genotype (OR=2.7 [1.20–
6.12], p=0.019) and higher SLE (OR=2.34 [1.04–5.30], p=0.041), while 
personality did not contribute significantly. These associations held and were 
even stronger when females were analysed separately. So, NPSR1 appears as an 
independent predictor of both suicide attempts and affective/anxiety disorders, 
and contributes to the development of personality and impulsivity described in 
Paper I. Thus, the accumulation of harmful traits in that are magnified by 
adverse environment possibly lead to suicidal behaviour and ideation, and 
affective/anxiety disorders in females with the AA genotype. These phenotypes 
are correlated with each other and are likely to share underlying biology; 
nevertheless, they still are different dimensions with their own mechanisms of 
development; to which extent these are interwoven, requires further study. 
Thus, the NPSR1 genotype appears to represent a basic system involved in 
vulnerability to emotion dysregulation. 
The contribution of the NPSR1 AA genotype to affective/anxiety disorders is 
compatible with results of animal studies where less active NPS-ergic neuro-
transmission is associated with anxiety-related behaviour (Lukas & Neumann 
2012; Rizzi et al. 2008; Wegener et al. 2012; Xu et al. 2004). In addition, very 
recent evidence points to the involvement of A-allele in anxiety-related 
psychopathology in humans: Subjects with the AA genotype were reported to 
have higher trait anxiety in one study (Glotzbach-Schoon et al. 2013); in others, 
the A-allele carriers had more likely early onset obsessive-compulsive disorder 
(Lennertz et al. 2013), and were over-represented among patients with 
schizophrenia (Lennertz et al. 2012) which is not surprising as anxiety may be 


























































































































































































































































































































































































Depressiveness at age 25 
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Trait anxiety at age 25 
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Depressiveness at age 18 
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Table 2 Predicting suicide attempts by personality reported 3 years earlier in combined 
cohorts of the ECPBHS, results from simultaneous logistic regression. Bold – 







Sex (females) 8.53 0.003 5.61 [1.76–17.8] 
NPSR1 (AA vs T-allele) 6.58 0.010 2.84 [1.28–6.32] 
Neuroticism 0.03 0.863 1.04 [0.66–1.63] 
Extraversion 5.40 0.020 0.60 [0.39–0.92] 
Openness to experience 0.32 0.571 0.86 [0.58–1.35] 
Agreeableness 0.43 0.514 0.87 [0.58–1.32] 
Conscientiousness 0.15 0.702 0.91 [0.56–1.48] 
SLE at age 15 (high) 7.12 0.008 3.11 [1.35–7.15] 
Constant 19.7 <0.001  
 
 
As mentioned above, these new findings of ours, and others, are in an apparent 
contrast with the original suggestion that the NPSR1 T-allele is associated with 
panic disorder (Domschke et al. 2011; Donner et al. 2010; Okamura et al. 2007) 
that belongs to the group of anxiety disorders. To reconcile the inconsistency 
with animal studies that rather suggest the A-allele as anxiety-related, the 
NPSR1-associated panic disorder was hypothesized to arise from arousal 
mechanisms, not anxiety (Domschke et al. 2011; Okamura et al. 2007), as NPS-
ergic transmission is associated with higher arousal/activity in both animal (e.g., 
Guerrini et al. 2010; Smith et al. 2006) and human studies (e.g., Domschke et 
al. 2011; Paper I). The biological differentiation of panic disorder from anxiety 
would be in accordance with Panksepp`s theory of basic limbic emotional 
action systems, the primary sources of fear response and panic being in 
neurobiologically independent domains (Panksepp 1998; Panksepp 2005). 
Higher arousal does not have to lead to anxiety-related psychopathology (panic 
disorder set aside), given that NPS has the unique pattern of effects in animals, 
being concurrently stimulant and anxiolytic (e.g., Pape et al. 2010). Instead, the 
higher arousal and reactivity of the amygdala / dorsal anterior cingulate cortex / 
dorsomedial PFC system (Dannlowski et al. 2011; Raczka et al. 2010) as well 
as the less prominent cortical activation in response to emotional stimuli (Tupak 
et al. 2013) in T-allele carriers could indicate decreased inhibitory control (Kim 
& Lee 2011). Impulsive action that is more characteristic to subjects with the 
TT genotype (Papers I and IV) may thus contribute rather specifically to e.g., 
panic disorder and bipolar disorder. Indeed, lower activity of dorsolateral PFC 
is observed in panic disorder and post-traumatic stress disorder, but in case of 
anxiety disorders that involve worry and rumination (recursive self-focused 
thinking) such as generalized anxiety and obsessive-compulsive disorder, the 
PFC is characteristically more active (Berkowitz et al. 2007; Strawn et al. 
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2012). Also rumination in depression is associated with increased activation in 
limbic areas and in dorsolateral PFC (Cooney et al. 2010). Consistent with this 
notion, AA subjects have high activity in dorsolateral PFC (Domschke et al. 
2011; Tupak et al. 2013). Thus, increased dorsolateral PFC activity in subjects 
with the AA genotype may not only be an indicator for stronger amygdala input 
suppression but also for repetitive self-focused thinking. In addition, rostral 
dorsomedial PFC activity is reduced in depressed females in response to 
negative stimuli (Moses-Kolko et al. 2010) similarly to subjects with the AA 
genotype in the Raczka et al. (2010) study. Repetitive thoughts may also 
represent a constructive form of cognitive coping strategies like planning, 
problem solving and rehearsal (Watkins 2008). In line with this, subjects with 
the AA genotype appear as being able to take advantage of favourable 
environments, as they had on average the highest level of self-esteem, elevated 
extraversion and adaptive impulsivity as well as the lowest anxiety and 
neuroticism (Papers I and II). 
Essentially in consistency with animal studies where NPS has influenced the 
function of the HPA axis (Paneda et al. 2009; Smith et al. 2006), male T-allele 
carriers (no females were tested) had larger salivary cortisol responses to social 
stress in laboratory (Kumsta et al. 2013). The authors concluded that the  
T-allele represents one vulnerability factor to stress- and anxiety-related 
disorders if carriers were subjected to chronic stress. Again, this would however 
apparently contradict animal studies where higher NPS activity, that has 
stronger influence on the HPA axis, is simultaneously arousal-promoting and 
anxiolytic (e.g. Pape et al. 2010; Smith et al. 2006; Xu et al. 2004), and 
facilitates fear extinction (Han et al. 2013; Lukas & Neumann, 2012; Okamura 
et al. 2011). However, there is substantial difference between acute and 
chronically active stress response, with the first being adaptive/mobilising and 
the latter possibly having detrimental consequences on health (Chrousos 2009; 
Luine 2007; Nugent et al. 2011). So cortisol measurement one hour after social 
stress test as in Kumsta et al. (2013) provides no sufficient information to 
conclude on long-term effects of NPSR1 on neuroendocrine and stress response. 
Evidence from Paper I agrees that T-allele carriers do respond to SLEs with 
maladaptive traits (higher impulsivity and hyperactivity) but these are AA 
homozygotes instead who react to adverse family environment with persistent 
changes in maladaptive traits (Papers I and II) that could accumulate and 
convert into affective/anxiety disorders (Paper II) that quite obviously do not 
develop overnight (Harro and Oreland 2001).  
The effects of NPSR1 as described in Paper II were generally female-
dominant. Sex-dependent effects of NPSR1 were found also by Dannlowski et 
al. (2011), Domschke et al. (2011), Okamura et al. (2007), and in studies 
leading to Paper I. The biological underpinnings behind the relative sex-
specificity of the NPSR1 associations could possibly be explained by the action 
of NPS on monoaminergic system (Didonet et al. 2014; Raiteri et al. 2009; Si et 
al. 2010) and on CRF release (Paneda et al. 2009; Smith et al. 2006). Sex-
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specific neurochemical changes have been documented both in monoaminergic 
system (e.g., Jovanovic et al. 2008; Mällo et al. 2009; Van den Hove et al. 
2014) and CRF function (Bangasser et al. 2010), and these differences are 
thought to explain sex differences in the prevalence of affective and anxiety 
disorders.  
In conclusion, our findings suggest that the NPSR1 A/T polymorphism is 
associated with affective and anxiety disorders and suicidal behaviour in a sex- 
and environment-dependent manner. It appears that in females the AA genotype 
and adverse family relations could lead to affective dysregulation, suicide 
attempts and internalizing psychopathology.  
 
 
4.4. NPSR1 × environment effects: contribution to  
alcohol consumption and alcohol use disorders (Paper III) 
Given that NPSR1 influences traits that are associated with substance use 
(Papers I, II and IV), and the involvement of the NPS system in addictive 
behaviours in rodent studies (reviewed by Cannella et al. 2013), we 
hypothetised that the NPSR1 A/T polymorphism may contribute in a complex, 
certainly sex-dependent manner to alcohol use disorders (AUD) and alcohol 
use. 
We indeed found that the associations of the NPSR1 genotype with alcohol 
use and AUD were significant but differed by sex. In females, both AUD and 
excessive alcohol use were more prevalent in subjects with at least one A-allele. 
In contrast, AUD in males was more prevalent in carriers of the high-activity 
related T-allele, and especially so if the subjects had been exposed to environ-
mental adversity in adolescence. Thus, male T-allele carriers had consumed 
alcohol more excessively in adolescence. It was surprising to find that the risk 
allele for higher alcohol use at age 25 was the A-allele in both females and 
males. This may relate to distinct pathways to higher alcohol use, as discussed 
below. 
After testing the associations with personality traits that were found to be 
associated with NPSR1 (Paper I) and are known to affect alcohol use, most of 
the genotype effects become weaker or disappeared. This suggests that NPSR1 
effects on AUD and alcohol use are at least partly mediated by personality.  
The sex and time dependent nature of NPSR1 associations with AUD and 
alcohol use are in line with the overall personality and impulsivity regulating 
role of NPSR1 as found in studies described in Papers I, II and IV. Again, the 
NPSR1 sex-specific effects could be explained by the NPS system interactions 
with monoaminergic systems (Didonet et al 2014; Mochizuki et al. 2010; 
Raiteri et al. 2009; Si et al. 2010) and HPA function (Cannella et al. 2009; 
Jüngling et al. 2012; Smith et al. 2006) that are known to play role in sex 
differences both in stress responses (Bangasser et al. 2010) but also in alcohol 
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abuse (reviewed by Witt 2007). We have presented data-driven developmental 
pathways to AUD in males and females by NPSR1 genotype in Figure 8. 
Subjects with higher neuroticism and emotion dysregulation tend to use 
alcohol because of its acute anxiolytic effects (Bolton, Robinson & Sareen 
2009; Chartier et al. 2010; Kushner et al. 2011). This may apply to female A-
allele carriers of this study as the genotype effects on AUD and alcohol use 
were mostly explained by neuroticism. They also reported feeling more relaxed 
and happier when drinking compared to the T-allele carriers, and this may refer 
to the regulation of negative emotions by alcohol use. Moreover, female  
A-allele carriers in this sample were vulnerable for affective and anxiety 
disorders (Paper II) and all females with anxiety/affective disorders comorbid 
with AUD were A-allele carriers. The harmful use of alcohol and AUD is 
indeed common among individuals with affective and anxiety disorders (e.g., 
Bolton et al. 2009; Kleinberg, Aluoja & Vasar 2010; Kushner et al. 2011). As 
alcohol dependence is considered to be related to overall internalizing 
psychopathology load rather than to a particular disorder (Kushner et al. 2012), 
we suggest that in females the lower NPS-ergic activity bears a risk for affective 
and anxiety-related dysregulation that renders them vulnerable also to alcohol 
use. 
Contrary to females, the risk allele for AUD in males was the T-allele. The 
likelihood for the disorder in T-allele carriers was even higher if adverse 
environmental factors were accounted for. The pattern of more excessive 
alcohol use of male T-allele carriers was observed already at age 15. We have 
shown that subjects with the T-allele are more impulsive and hyperactive 
(Papers I and IV), and sensitive to stressful life events that increase disinhi-
bition (Paper I). Early-age initiation of alcohol consumption and poor impulse 
control, which are often related, are both risk factors for developing substance 
use disorders (Diemen et al. 2008; Iacono et al. 2003). So development of 
alcohol addiction in males with at least one T-allele may possibly depart from 
initial higher activity/impulsivity level: these subjects start with larger quantities 
of alcohol, then stressful life events further accentuate disinhibition that loosens 
the control over alcohol consumption and leads to alcohol abuse, allowing the 
drug to take control. This hypothesis is supported by significant association of 
extraversion, adaptive and maladaptive impulsivity, hyperactivity and stressful 
life events with alcohol use and AUD in this study. In adolescents and young 
adults, early stages of heavy alcohol use are characterised by impulsive drinking 
(Heilig & Koob 2007) where activity of the mesolimbic dopaminergic system 
plays a crucial role (reviewed by Vengeliene et al. 2008). As NPS stimulates 
dopaminergic activity (Didonet et al. 2014; Mochizuki et al. 2010; Si et al. 
2010), males with the high-activity T-allele could be especially vulnerable to 




Figure 8 Proposed pathways to alcohol use disorders (AUD) in males and females by 
NPSR1 genotype. In females, the lower NPS-ergic activity in A-allele carriers and 
especially in AA homozygotes bears a risk for affective and anxiety-related 
dysregulation already in adolescence (Paper II) that also renders them vulnerable to 
alcohol use. Consequently, some females carrying the A-allele develop AUD already in 
young adulthood. In males, an impulsivity-related early-onset pathway to AUD occurs 
in T-allele carriers and in particular in TT-homozygotes: already in adolescence, they 
exhibit more ADHD symptoms and impulsivity (Paper I) that make them vulnerable to 
alcohol use, especially when experiencing adverse environment (Paper I). As a 
consequence, many males carrying the T-allele develop AUD by young adulthood. In 
males, a delayed-onset pathway to AUD is also suggested for the AA genotype: the 
increase of adaptive impulsivity, extraversion and openness to experience by age 25 in 
males with AA genotype (Paper I) can make them vulnerable to higher alcohol use. 
However, future studies have to reveal whether AUD will develop on this basis in male 
AA subjects in later age. ADHD traits – ADHD-related traits; imp – impulsivity; 
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Interestingly, the risk allele for higher alcohol use was not T-allele anymore by 
young adulthood, and more alcohol was consumed by males with the AA 
genotype instead. This discrepancy can be explained by the significant 
progression of adaptive impulsivity from adolescence to age 25 in males with 
the AA genotype (Paper I) that is generally beneficial but is also associated 
with substance use, and possibly very much so in a country with a general high 
level of alcohol consumption. Indeed, AA genotype effects on alcohol use in 
males were explained by both high adaptive impulsivity and neuroticism. 
Again, future studies will have to test whether AUD will develop in male AA 
subjects in later age than in T-allele carriers. 
 
 
4.5. Neuropeptide S receptor gene (NPSR1) A/T 
polymorphism and sleep (Paper V) 
Consistent with animal studies where higher NPS-ergic activity is associated 
with reduced sleeping time and increased wakefulness (e.g., Xu et al. 2004; 
Zhao et al. 2012), the T-allele carriers had later bedtime in a study of circadian 
phenotypes by Gottlieb et al. (2007). However, subjects with the AA genotype 
had higher prevalence of affective/anxiety disorders (Paper II) and higher trait 
anxiety (Paper II; Glotzbach-Schoon et al. 2013) that go hand in hand with 
sleep problems (reviewed by Shochat et al. 2014). But sleep disturbances and 
shorter sleep duration are also associated with hyperactivity (Ganelin-Cohen & 
Ashkenasi 2013) that appears as characteristic to T-allele carriers (Papers I and 
IV). Except the GWAS quoted above (Gottlieb et al. 2007), no study has been 
published to date on NPSR1 link to sleep difficulties.  
In the present analysis, NPSR1 rs324981 (A/T) polymorphism was associated 
with both bedtime and sleep duration, and also with sleep-related problems.  
The NPSR1 association with bedtime changed with age. While subjects with 
the AA genotype had the latest bedtime in childhood and middle adolescence, 
no differences in bedtime were observed at age 18, and in young adulthood at 
age 25, those were subjects with the TT genotype who had the latest bedtime. 
We also found age-dependency in effects of NPSR1 on personality and alcohol 
use in these birth cohorts (Papers I and III) and this is not surprising as 
adolescence is a period with rapid changes in the CNS (reviewed by Casey et al. 
2008). As mentioned above, the latest bedtime in adult TT homozygotes was 
previously reported by Gottlieb et al. (2007), and these results are consistent 
with animal studies where higher NPS-ergic activity is associated with reduced 
sleep (Camarda et al. 2009; Hirota et al. 2009; Jüngling et al. 2008; Rizzi et al. 
2008; Smith et al. 2006; Xu et al. 2004).  
Reduction of sleep time by NPSR1 in the ECPBHS sample was observed 
only when environmental factors were accounted for, and only in adulthood. At 
age 25, the latest time point available, subjects with the TT genotype slept less 
if they had reported higher number of stressful life events (SLE) in adolescence; 
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and subjects with the AA genotype had shorter sleeping time if they had 
experienced adverse family environment. G × E effects were present also in 
case of sleep-related problems: again more problems were reported by subjects 
with the AA genotype in case of adverse family environment, and by subjects 
with the TT in case of high SLE. One has to recall that the preferential 
sensitivity of TT genotype to SLEs and AA to family environment was also 
found in associations of NPSR1 with personality and hyperactivity (Paper I). 
Consistently, subjects with the TT genotype reported higher anxiety sensitivity 
in Klauke et al. (2014) if they had experienced higher number of adverse life 
events. In ECPBHS, subjects with the AA genotype more often reported suicide 
attempts and were diagnosed with an affective/anxiety disorder in case of 
adverse family environment (Paper II).  
NPSR1 had effects on sleep-related difficulties in both birth cohorts of the 
ECPBHS but the effects were different. In the older cohort, subjects with the 
AA genotype had the highest number of sleep-related problems whereas 
subjects with the TT genotype had the least problems (Figure 9). However, in 
AA homozygotes the high frequency of sleep problems depended on adverse 
family environment in adolescence. In the younger cohort, similarly, higher 
scores in AA homozygotes in case of less warm family environment were 
observed, but the association emerged at later age. Higher frequency of sleep-
related problems in subjects with the AA genotype, especially when 
experiencing adverse family environment, was expected as we had found that 
subjects with the AA genotype had higher prevalence of affective/anxiety 
disorders, the highest frequency of suicide attempts and the highest scores of 
depressiveness and anxiety, if reporting adverse family environment in late 
adolescence (Paper II). In addition, AA homozygotes had higher prevalence of 
   
 
Figure 9 NPSR1 effects in sleep-related difficulties in the older cohort of the ECPBHS. 
(a) NPSR1 main effect, t=–2.36, p=0.019. (b) NPSR1 × warmth effect, t=2.48, p=0.014. 
* p<0.05, *** p<0.001, differences from AT or TT genotype, or AT&TT/ different 






































































Table 3 Predicting affective/anxiety disorders in the older cohort of the ECPBHS, 







Sex (females) 9.01 0.003 2.76 [1.42–5.36] 
NPSR1 (AA vs T-allele) 0.44 0.507 1.40 [0.52–3.82] 
Sleep-related problems 0.90 0.341 0.96 [0.88–1.05] 
Bedtime 0.95 0.330 1.20 [0.83–1.74] 
Sleep duration 0.43 0.513 0.79 [0.39–1.60] 
SLE at age 15 (high) 4.18 0.041 1.99 [1.03–3.86] 
Warmth in the family 0.62 0.431 0.75 [0.37–1.54] 
NPSR1 × Warmth (AA/low) 6.51 0.011 5.79 [1.50–22.3] 
Constant 9.67 0.002  
 
4.6. Closing remarks 
In this dissertation, we have concentrated on neuropeptide S (NPS) receptor 
NPSR1 gene functional rs324981 A>T polymorphism (Asn107Ile), that is rela-
tively newly identified research target. We have demonstrated that NPSR1 
influences the development of personality, hyperactivity, anxiety, depressive-
ness, self-esteem, suicidality, affective/anxiety disorders, alcohol use and 
alcohol use disorders, and sleep-related measures.  
Association of NPSR1 with various physiological and psychological 
measures is not surprising as NPS and NPSR are localised in brain areas that 
 
III). Involvement of the A-allele in trait anxiety and in obsessive-compulsive 
disorder was found also by Glotzbach-Schoon et al. (2013) and Lennertz et al. 
(2013), and is expected from animal studies (e.g., Pape et al. 2010). So, sleep-
related problems in subjects with AA genotype that were already observable at 
age 15 most likely reflect affective dysregulation that could lead to psychiatric 
disorders diagnosed in young adulthood, as sleep-related problems have been 
found to be in positive correlation with depression symptoms (reviewed by 
Shochat et al. 2014). However, further analysis revealed that significant 
predictors for affective/anxiety disorders were sex, higher number of SLEs and 
NPSR1 AA genotype in combination with adverse family environment; whereas 
bedtime, sleep duration and sleep-related problems recorded at age 15 were not 
associated with the disorder later in life (Table 3). This could mean that NPSR1 
independently influences both sleep-related measures and affective/anxiety-
related dysregulation.  
alcohol use disorder that appeared as developmentally related to anxiety (Paper 
49 
regulate basic physiological functions like arousal and circadian rhythms. In 
addition, NPS is known to modulate HPA axis function and the release of 
monoamines that could explain the sex, age and environment-dependent effects.  
Our findings suggest that the NPSR1 A/T polymorphism is associated with 
affective and anxiety disorders, suicidal behaviour, and alcohol use disorders in a 
sex- and environment-dependent manner. The genotype by sex/gender 
interactions were profound. In females, the lower NPS-ergic activity in A-allele 
carriers and especially in AA-homozygotes bears a risk for affective and anxiety-
related dysregulation already in adolescence. The risk for developing maladaptive 
traits is significantly higher in case of adverse family environment. As a 
consequence, females with the AA genotype had reported suicidal behaviour 
more frequently and had developed affective/anxiety disorders by age 25. 
Affective and anxiety related dysregulation may render them vulnerable also to 
alcohol use. Consequently, some females carrying the A-allele develop AUD 
already in young adulthood.  
In males, an impulsivity-related early-onset pathway to AUD occurs in T-
allele carriers and in particular in TT-homozygotes: already in adolescence, they 
exhibit more ADHD symptoms and impulsivity that make them vulnerable to 
alcohol use, especially when experiencing adverse environment. As a 
consequence, many males carrying the T-allele develop AUD by young 
adulthood. In males, a delayed-onset pathway to AUD is also suggested for the 
AA genotype: the increase of adaptive impulsivity, extraversion and openness 
to experience by age 25 in males with AA genotype can make them vulnerable 
to higher alcohol use. However, future studies have to reveal whether AUD will 
develop on this basis in male AA subjects in later age. 
NPSR is clearly a tempting target for drug development as it affects emotion 
regulation, arousal and alcohol abuse. E.g., nasal administration of NPS 
demonstrated by Lukas & Neumann (2012) in animals could lower anxiety and 
promote behavioural activation in humans in case of affective/anxiety disorders 
as well but possible side effects including panic attacks in some individuals 
elicited by higher autonomic arousal caused by higher NPSergic activity 
warrant more studies. So, although the results presented in this dissertation are 
based on population-representative samples, the NPSR1 influence on various 
measures while accounting with environment should be tested on other ethnic 
groups, and in different types of societies as well. In addition, future directions 







We have found that the functional NPSR1 A/T polymorphism (Asn107Ile) is 
associated with various measures in general population in age-, sex- and 
environment-dependent manner.  
1. NPSR1 genotype is associated with personality, but this association will 
become apparent mostly by young adulthood due to changes in scores from 
age 18 to 25. The TT genotype effects on personality could be interpreted 
as adverse, especially in women. The effects of the AA genotype on 
personality were advantageous, especially in the case of a favourable 
family environment, and more so for men. However, sensitivity of the AA 
genotype to family environment could lead to detrimental changes in 
personality, e.g., higher neuroticism and lower extraversion, in both sexes.  
2. NPSR1 T-allele carriers, especially male TT homozygotes, exhibited high 
levels of ADHD-related symptoms and impulsivity that were further 
accentuated by stressful life events. While NPSR1 was associated with 
hyperactive/inattentive behaviour as rated by teachers already durig the 
childhood of the subjects, NPSR1 related changes in self-reported 
impulsivity emerged more prominently in young adulthood. 
3. Females with the NPSR1 AA genotype who had reported adverse family 
environment in adolescence had higher scores of trait anxiety and 
depressiveness, and lower self-esteem. Male AA homozygotes had higher 
depressiveness only in case of adverse family relations.  
4. The hypothesised high vulnerability of AA genotype to emotion 
dysregulation was corroborated by the highest prevalence of affective/ 
anxiety disorders by age 25 in female AA homozygotes who had experien-
ced adverse family environment in adolescence.  
5. Female AA homozygotes also reported suicidal behaviour more frequently, 
and again, this association was further accentuated by adverse family 
environment. 
6. In females, both AUD and harmful alcohol use were more prevalent in A-
allele carriers. In contrast, in males, AUD was more frequent in T-allele 
carriers, especially if exposed to adverse environments during adolescence. 
Alcohol use was higher in male T-allele carriers in adolescence as well. 
However, in adulthood, the risk allele for higher alcohol use for males was 
the A-allele as in females, suggesting distinct pathways to higher alcohol 
use by NPSR1 in males. 
7. The associations of NPSR1 with AUD and alcohol use were mediated by 
personality and hyperactivity. This is in line with the hyperactivity/ 
impulsivity and personality regulating role of the NPSR1 that differs in 
males and females. In females, the probable lower NPS-ergic activity in  
A-allele carriers and especially in AA-homozygotes bears a risk for 
affective and anxiety-related dysregulation already in adolescence that also 
renders these subjects vulnerable to alcohol use. Consequently, some 
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females carrying the A-allele develop AUD already in young adulthood. In 
males, an impulsivity-related early-onset pathway to AUD occurs in T-
allele carriers and in particular in TT-homozygotes: already in adolescence, 
they exhibit more ADHD symptoms and impulsivity that make them 
vulnerable to alcohol use, especially when experiencing adverse environ-
ment. As a consequence, many males carrying the T-allele develop AUD 
by young adulthood. In males, a delayed-onset pathway to AUD is also 
suggested for the AA genotype: the increase of adaptive impulsivity, 
extraversion and openness to experience by age 25 in males with AA 
genotype can make them vulnerable to higher alcohol use. However, future 
studies have to reveal whether AUD will develop on this basis in male AA 
subjects in later age. Nevertheless, altogether these findings highlight the 
possibility that variants of a single gene can contribute to the development 
of a psychiatric disorder through several behavioural and neurobiological 
pathways. 
8. The NPSR1 A/T polymorphism is associated with sleep-related pheno-
types. While the AA genotype was associated with higher frequency of 
sleep-related problems both at adolescence and adulthood, and later 
bedtime in adolescence, the TT genotype was associated with later bedtime 
in adulthood. Both AA and TT homozygous subjects slept less in 
adulthood if they had experienced adverse environment in adolescence. 
These associations of genotype and sleep could in part explain the 
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SUMMARY IN ESTONIAN 
Neuropeptiid S ja vaimne tervis: NPS retseptori genotüübi ja  
keskkonna roll isiksuseomaduste ja psühhiaatriliste häirete kujunemisel 
Hiljutiavastatud neuropeptiid S (NPS) avaldab närilistel omapärast mõju, 
suurendades aktiivsust ja virgust samaaegselt ärevuse alandamisega. Inimesel 
on NPS retseptori geenis NPSR1 funktsionaalne A>T polümorfism (rs324981), 
mille T-alleeli kooditud retseptorvalk on signaali vahendamisel tõhusam.  
T-alleeli kandlus on seotud suurema virguse, kuid ka paanikahäirega, mistõttu 
on T-alleeli hakatud pidama riskialleeliks. Väitekirjas kajastatud rahvastiku-
põhiste uuringutega lõime tasakaalustatuma pildi NPSR1 toimimisest, leides nii 
soost, vanusest kui keskkonnast sõltuvaid seoseid.  
NPSR1 T-alleeliga isikud, eriti TT genotüübiga mehed, olid hüperaktiivse-
mad ja impulsiivsemad, ning stressirikkad elusündmused rõhutasid neid 
omadusi veelgi. Kui NPSR1 mõjutab aktiivsus-tähelepanuhäirega seotud käitu-
mist õpetajate hinnangute alusel juba lapseeas, siis genotüübi seosed enese-
raporteeritud impulsiivsuse ja muude isiksuseomadustega avaldusid tugevamalt 
täiskasvanueas tänu muutustele 18-ndast 25-nda eluaastani. TT genotüübi mõju 
isiksusele võiks tõlgendada pigem ebasoodsana, ja seda eriti naiste jaoks. See-
vastu AA genotüübiga uuritavatel, eriti meestel, oli soodsam isiksuseprofiil, ja 
seda eriti heade peresuhete korral. Samas reageerisid mõlemast soost AA 
genotüübiga isikud tugevalt kehvale perekeskkonnale neurootilisuse ja mala-
daptiivse impulsiivsuse kasvu ning ekstravertsuse ja adaptiivse impulsiivsuse 
alanemisega.  
Leidsime, et naistel, kellel on madalaima aktiivsusega NPSR1 genotüüp, AA, 
võib juba teismeeas meeleolu ja ärevuse regulatsiooniga raskusi olla. Mitte-
adaptiivsed jooned ilmnesid neil sagedamini just kehvade peresuhete korral ja 
väljendusid kõrgemates püsiärevuse ja depressiivsuse skoorides ning madalas 
enesehinnangus. AA genotüübi oletatav emotsionaalne haavatavus leidis veelgi 
kinnitust: kõige rohkem afektiivseid ja ärevushäireid esines 25ndaks eluaastaks 
neil AA genotüübiga naistel, kes olid kogenud teismelisena kehvi peresuhteid. 
AA genotüübiga naised raporteerisid 18-aastaselt ka kõige sagedamini 
enesetapukatseid, ja jällegi oli seos tugevam just kehvade peresuhete korral.  
NPSR1 oli seotud ka alkoholi kuritarvitamise ja alkoholisõltuvusega. Naistel 
olid nii alkoholi kuritarvitamine kui sõltuvushäire sagedasemad A-alleeli 
kandjatel. Seevastu meestel esines oluliselt rohkem teismeea alkoholitarvitamist 
ning sõltuvushäireid T-alleeli kandjate hulgas, ja seda eriti teismelisena kogetud 
stressirikaste elusündmuste puhul. Ometi oli meestel täiskasvanuna sarnaselt 
naistega alkoholitarvitamise riskialleeliks A-alleel, mis viitab meestel NPSR1-st 
sõltuvatele erinevatele alkoholitarvitamise mustritele. Kuna NPSR1 seoseid 
sõltuvushäirete ja alkoholi tarbimisega vahendasid isiksusejooned ja impul-
siivsus, sobides kokku NPSR1 sooti erineva rolliga hüperaktiivsuse/impul-
siivsuse ja isiksuse kujundamisel, saab kirjeldada järgnevaid sõltuvuse 
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tekkimise radasid. A-alleeliga naistel, eriti AA homosügootidel, tähendab tõe-
näoliselt madalam NPS-egiline aktiivsus raskusi meeleolu ja ärevuse regulat-
siooniga juba teismeeas, mis teeb nad alkoholi tarvitamisele vastuvõtlikuks. 
Seega kujunes osadel A-alleeliga naistest 25ndaks eluaastaks välja alkoholi-
sõltuvushäire. Meestel eksisteerib impulsiivsusega seotud varajase algusega 
sõltuvuse tekkimise rada: NPSR1 T-alleeliga mehed, eriti TT homosügoodid, 
olid hüperaktiivsemad ja impulsiivsemad, mis tegi nad vastuvõtlikuks alkoholi 
tarvitamisele, eriti stressirikkaid elusündmusi kogedes. Seetõttu pole üllatav, et 
T-alleeliga meeste hulgas oli oluliselt rohkem sõltuvushäireid. Nagu mainitud, 
raporteerisid huvitaval kombel sarnaselt naistega alkoholiga liialdamist täis-
kasvanuna hoopis AA genotüübiga mehed, mis viitab võimalikule täiendavale 
hilise algusega sõltuvuse tekkimise rajale: AA meestel tõusid adaptiivne impul-
siivsus ja avatus oluliselt 25-ndaks eluaastaks, ning nad olid ka alkoholi 
kuritarvitamisele vastuvõtlikumad. Kas neil ka hiljem sõltuvus kujuneb, jääb 
tulevikus selgitada. 
NPSR1 A/T polümorfism on seotud ka erinevate unefenotüüpidega. AA 
genotüübiga isikutel oli sagedamini uneprobleeme nii teismeeas kui täis-
kasvanuna, ja nad läksid teismelisena hiljem magama; seevastu TT genotüübiga 
isikud läksid täiskasvanuna hiljem magama. Nii AA kui TT homosügoodid 
magasid täiskasvanuna lühemat aega, kui nad olid teismelisena halvemat 
keskkonda kogenud. Genotüübi seosed uneprobleemidega sobivad NPSR1 rolli 
selgitamiseks psühhiaatrilistes häiretes.  
NPSR on huvipakkuv sihtmärk ravimiarenduseks, kuna mõjutab virgust, 
emotsionaalseid reaktsioone ja alkoholi kuritarvitamist. Analoogselt loomkatse-
tega võiks NPSi ka inimestel kasutada näiteks meeleolu- ja ärevushäirete puhul 
käitumusliku aktiviseerijana ja ärevuse alandajana. Samas aga tuleks uurida ja 
olla ettevaatlik võimalike kõrvaltoimete suhtes, kaasa arvatud võimalus, et 
NPS-i indutseeritud autonoomse närvisüsteemi aktivatsioonist tekivad mõnel 
inimesel paanikahood. Kuigi väitekirjas esitatud tulemused on saadud 
rahvastikupõhiseid valimeid kasutades, tuleks NPSR1 mõju koostoimes 
keskkonnaga uurida ka teistel etnilistel gruppidel ja erinevates ühiskondades. 
Eraldi tähelepanu tuleks suunata AA ja TT homosügootide erinevate 
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